No studies, to our knowledge, have comprehensively explored evidence for bimodal age distribution at diagnosis across quantitative protein-based (i.e., percent ER-positivity) or RNA-based (i.e., ESR1 and PAM50) tumor characteristics. The gene discussed is ESR1; the disease is neoplasm.